Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Vredenburgh

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cancer|August 25, 2005
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066Jeffrey Peppercorn, James Herndon, Alice B Kornblith, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Chemotherapy and novel therapeutic approaches in malignant gliomaAnnick Desjardins, Jeremy N Rich, Jennifer A Quinn, et al.
Cancer|November 24, 2004
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant gliomaDavid A Reardon, Jennifer A Quinn, James Vredenburgh, et al.
The Oncologist|April 19, 2018
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant GliomaMary Lou Affronti, Jennifer Gamboa Jackman, Frances McSherry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2003
Unrelated umbilical cord blood transplantation in adult patientsGwynn D Long, Mary Laughlin, Bella Madan, et al.
Journal of Neuro-Oncology|March 29, 2006
Incidence and patterns of neuraxis metastases in children with diffuse pontine gliomaSridharan Gururangan, Colleen A McLaughlin, James Brashears, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent GlioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology|May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumabJeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cancer|August 25, 2005
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066Jeffrey Peppercorn, James Herndon, Alice B Kornblith, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Chemotherapy and novel therapeutic approaches in malignant gliomaAnnick Desjardins, Jeremy N Rich, Jennifer A Quinn, et al.
Cancer|November 24, 2004
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant gliomaDavid A Reardon, Jennifer A Quinn, James Vredenburgh, et al.
The Oncologist|April 19, 2018
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant GliomaMary Lou Affronti, Jennifer Gamboa Jackman, Frances McSherry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2003
Unrelated umbilical cord blood transplantation in adult patientsGwynn D Long, Mary Laughlin, Bella Madan, et al.
Journal of Neuro-Oncology|March 29, 2006
Incidence and patterns of neuraxis metastases in children with diffuse pontine gliomaSridharan Gururangan, Colleen A McLaughlin, James Brashears, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent GlioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology|May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumabJeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Pageof 4